BNP Paribas Financial Markets acquired a new position in Ardent Health Partners, LLC (NYSE:ARDT – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 2,301 shares of the company’s stock, valued at approximately $42,000.
Other hedge funds also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. purchased a new position in shares of Ardent Health Partners during the 3rd quarter worth $526,000. Financial Management Professionals Inc. purchased a new stake in shares of Ardent Health Partners in the 3rd quarter worth $50,000. Allspring Global Investments Holdings LLC bought a new position in Ardent Health Partners in the 3rd quarter worth $13,119,000. Finally, Seven Grand Managers LLC bought a new position in Ardent Health Partners in the 3rd quarter worth $2,298,000.
Wall Street Analyst Weigh In
Several research firms have issued reports on ARDT. Stephens reissued an “overweight” rating and set a $24.00 price target on shares of Ardent Health Partners in a report on Thursday, September 19th. Leerink Partners boosted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday. Finally, Royal Bank of Canada restated an “outperform” rating and set a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $22.00.
Ardent Health Partners Stock Performance
Shares of NYSE:ARDT opened at $16.05 on Friday. The stock’s fifty day moving average is $17.30. Ardent Health Partners, LLC has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.
About Ardent Health Partners
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
- Five stocks we like better than Ardent Health Partners
- How to Invest in Blue Chip Stocks
- Micron Stock Under $100: Seize the AI-Driven Upside
- Airline Stocks – Top Airline Stocks to Buy Now
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health Partners, LLC (NYSE:ARDT – Free Report).
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.